1F-6 Transiently Increased Endothelial Layer Permeability by Ultrasound-activated Microbubbles

To enhance drug delivery to the extravascular tissue, a controlled, temporal and local increase in endothelial permeability is needed. Although recent studies have established that the permeability of single-cell membranes is increased by ultrasound in combination with contrast agents, it is not known whether this combination can also increase the permeability of an endothelial layer. To investigate endothelial layer permeability, we treated layers of human umbilical vein endothelial cells with ultrasound and the contrast agent BR14. Endothelial layer permeability was assessed by measuring the transendothelial electrical resistance (TEER) and permeability for fluorescein. Ultrasound in combination with BR14 significantly decreased TEER to 68.0 plusmn 3.1 % of initial values and temporally increased endothelial permeability for fluorescein by 38.1 plusmn 16.4 %. After treatment, no cell loss or damage was observed. In conclusion, ultrasound-activated BR14 microbubbles transiently increased the endothelial layer permeability. This feature may be used for future ultrasound-guided drug delivery systems

[1]  Nico de Jong,et al.  Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Alexander L. Klibanov,et al.  Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications , 2006, Investigative radiology.

[3]  Yun Zhou,et al.  Study of sonoporation dynamics affected by ultrasound duty cycle. , 2005, Ultrasound in medicine & biology.

[4]  A. Eggermont,et al.  Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats. , 2005, Cancer research.

[5]  Thierry Bettinger,et al.  Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[6]  A. Eggermont,et al.  Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies. , 2004, Journal of the National Cancer Institute.

[7]  I. Kurane,et al.  In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. , 2004, Journal of virological methods.

[8]  F. T. ten Cate,et al.  Radionuclide tumour therapy with ultrasound contrast microbubbles. , 2004, Ultrasonics.

[9]  G. Amerongen,et al.  Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. , 2002 .

[10]  B. Gewertz,et al.  Endothelial permeability and IL-6 production during hypoxia : role of ROS in signal transduction , 1999 .

[11]  P. Hedqvist,et al.  Kinetics of leukocyte‐induced changes in endothelial barrier function , 1998, British journal of pharmacology.

[12]  D. Morgan.  PERMEABILITY OF MYOCARDIAL CAPILLARIES TO HYDROPHILIC DRUGS: THE PARACELLULAR PATHWAY , 1996, Clinical and experimental pharmacology & physiology.

[13]  E. Dejana,et al.  Molecular Organization and Functional Regulation of Cell to Cell Junctions in the Endothelium , 1995, Thrombosis and Haemostasis.

[14]  R. Dean,et al.  Augmentation of Vascular Endothelial Barrier Function by Heparin and Low Molecular Weight Heparin , 1995, Thrombosis and Haemostasis.

[15]  W. Martin,et al.  Modulation of arterial endothelial permeability: studies on an in vitro model , 1989, British journal of pharmacology.